It is promising that ONC201 induces the same pro-apoptotic ligand as a clinically approved agent in CTCL, although the mechanism of vorinostat-mediated TRAIL gene upregulation is distinct from that of ONC201 [40]. Here, TNFSF10 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.